Treatment of Chinese Participants With B-Cell Malignancies With BGB-16673, a Bruton Tyrosine Kinase-Targeted Protein-Degrader
BeOne Medicines
BeOne Medicines
Lyell Immunopharma, Inc.
Novartis
Aurigene Discovery Technologies Limited
AstraZeneca
Eli Lilly and Company
Pfizer
Novartis
AVM Biotechnology Inc
BeOne Medicines
Nurix Therapeutics, Inc.
Verismo Therapeutics
Janssen Research & Development, LLC
Edwards Lifesciences
Regeneron Pharmaceuticals
Genmab
Adicet Therapeutics
Elixiron Immunotherapeutics (Hong Kong) Ltd.
Merck Sharp & Dohme LLC
Genmab
Genmab
Novartis
Novartis
iOnctura
Debiopharm International SA
Vironexis Biotherapeutics Inc.
AbbVie
AstraZeneca
Nurix Therapeutics, Inc.
Eli Lilly and Company